IMRIS

IMRIS proudly celebrates the dedication of our incredible team and their continued commitment to delivering best-in-class intraoperative MRI technologies for neurosurgeons and their patients. As a token of appreciation, senior leadership donned hats and aprons today to serve up a delicious waffle breakfast — a sweet way to say thank you!

IMRIS is excited to announce the appointment of Shalabh Chandra as our new CEO.

With deep roots in clinical science and a bold vision for the future, Shalabh is set to lead IMRIS into its next era of innovation and growth.

“The company is experiencing remarkable growth through the continued advancement of its InVision moving magnet systems. I’m thrilled to join a company so deeply dedicated to enhancing surgical outcomes for patients,” said Shalabh Chandra.

Welcome to IMRIS Shalabh!

IMRIS Imaging, Inc. Announces Shalabh Chandra as Chief Executive Officer IMRIS Imaging, Inc., the global leader in intraoperative imaging, is pleased to announce that its Board of Directors has appointed Shalabh Chandra as Chief

"In honor of MR Safety Week, I want to reaffirm a message that cannot be overstated: MRI Safety isn’t optional, it’s essential.

As a Senior Clinical Applications Specialist at IMRIS, I’ve seen firsthand the transformative power of MRI technology in advancing patient care. But with that power comes immense responsibility. Every magnet, every scan, every procedure demands vigilance, precision, and an unwavering commitment to safety.

The MRI doesn’t give second chances. That’s why safety isn’t just a policy, it’s a mindset. It’s about anticipating risk before it arises, fostering clear and open communication, investing in continuous education, and maintaining a healthy respect for the invisible but very powerful forces at work. It’s about empowering every team member to prioritize safety above all else.

Every safe scan reflects the care we give and the standards we uphold. MRI safety is a daily choice. A choice to protect, prevent, and lead. Let’s continue to choose wisely every time." Mekides Mezgebu, Senior Clinical Applications Specialist, IMRIS